Would the trial be allowed to continue to the next cohort (4) without good reason? IE a drop in viral load. Optimal therapeutic dose is one of the secondary endpoints. It's working or the trial would already be halted.
BLT Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held